Загрузка...
Unpredicted Severe Toxicity after 5-Fluorouracil Treatment due to Dihydropyrimidine Dehydrogenase Deficiency
Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the catabolism of 5-fluorouracil (5-FU). Thus, patients with a DPD deficiency are at risk of developing severe 5-FU-associated toxicity. A 37-year-old female with gastric cancer underwent a curative operation, followed...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Association of Internal Medicine
2006
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3891063/ https://ncbi.nlm.nih.gov/pubmed/16646564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.1.43 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|